Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo.

Abstract : UNLABELLED: ABSTRACT: BACKGROUND: Tissue plasminogen activator (tPA) exerts multiple functions in the central nervous system, depending on the partner with which it interacts. In particular, tPA acts as a positive neuromodulator of N-methyl-D-aspartate glutamatergic receptors (NMDAR). At the molecular level, it has been proposed that the pro-neurotoxicity mediated by tPA might occur through extrasynaptic NMDAR containing the GluN2D subunit. Thus, selective antagonists targeting tPA/GluN2D-containing NMDAR signaling would be of interest to prevent noxious effects of tPA. RESULTS: Here, we compared three putative antagonists of GluN2D-containing NMDAR and we showed that the new compound UBP145 ((2R*,3S*)-1-(9-bromophenan-threne-3-carbonyl)piperazine-2,3-dicarboxylic acid) is far more selective for GluN2D subunits than memantine and PPDA (phenanthrene derivative (2S*, 3R*)-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid). Indeed, in vitro, in contrast to the two other compounds, UBP145 prevented NMDA toxicity only in neurons expressing GluN2D (ie, in cortical but not hippocampal neurons). Furthermore, in cultured cortical neurons, UBP145 fully prevented the pro-excitotoxic effect of tPA. In vivo, we showed that UBP145 potently prevented the noxious action of exogenous tPA on excitotoxic damages. Moreover, in a thrombotic stroke model in mice, administration of UBP145 prevented the deleterious effect of late thrombolysis by tPA. CONCLUSIONS: In conclusion, tPA exerts noxious effects on neurons by acting on GluN2D-containing NMDAR and pharmacological antagonists of GluN2D-containing NMDAR could be used to prevent the ability of tPA to promote neurotoxicity.
Type de document :
Article dans une revue
Molecular Neurodegeneration, BioMed Central, 2011, 6 (1), pp.68. 〈10.1186/1750-1326-6-68〉
Liste complète des métadonnées

Littérature citée [44 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00637063
Contributeur : Ed. Bmc <>
Soumis le : samedi 29 octobre 2011 - 17:09:55
Dernière modification le : mercredi 6 juin 2018 - 01:25:13
Document(s) archivé(s) le : jeudi 15 novembre 2012 - 10:50:16

Fichiers

1750-1326-6-68.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Amandine Jullienne, Axel Montagne, Cyrille Orset, Flavie Lesept, David Jane, et al.. Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo.. Molecular Neurodegeneration, BioMed Central, 2011, 6 (1), pp.68. 〈10.1186/1750-1326-6-68〉. 〈inserm-00637063〉

Partager

Métriques

Consultations de la notice

273

Téléchargements de fichiers

224